L-454,560

Phosphodiesterase Inhibitor; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Asthma (Bronchial Asthma) 06/15/2007 - "L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition." 06/01/2006 - "L-454,560 is a potent phosphodiesterase 4 (PDE4) inhibitor which was identified as a development candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). "
2.	Chronic Obstructive Pulmonary Disease (COPD) 06/01/2006 - "L-454,560 is a potent phosphodiesterase 4 (PDE4) inhibitor which was identified as a development candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). "

1.	Phosphodiesterase 4 Inhibitors
2.	Type 4 Cyclic Nucleotide Phosphodiesterases